Journal Article Research Support, Non-U.S. Gov't Epublish 101 citations
PubMed: 37433819 DOI: 10.1038/s41598-023-36995-4
Long COVID prevalence and impact on quality of life 2 years after acute COVID-19.
Sci Rep 13(1):11207
Authors: Yoonjung Kim, Sohyun Bae, Hyun-Ha Chang, Shin-Woo Kim
Affiliations
- Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, 130, Dongdeok-ro, Jung-gu, Daegu, 41944, Republic of Korea.
- Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, 130, Dongdeok-ro, Jung-gu, Daegu, 41944, Republic of Korea.
Abstract
There has been an increasing interest in the long-term impact of long COVID. However, only a few studies have investigated the clinical manifestations of long COVID after 24 months of acute infection. In this study, prospective online surveys were conducted in adults previously diagnosed with coronavirus disease 2019 (COVID-19) in South Korea between February 13 and March 13, 2020, at 6, 12, and 24 months after COVID-19. We investigated self-reported symptoms and the EuroQol-5-dimension index. Among 900 individuals enrolled initially, 150 completed all 3 surveys. After excluding the cases of COVID-19 reinfection, 132 individuals were included in the final analysis. Among the 132 participants, 94 (71.2%) experienced symptoms of long COVID. The most frequently reported symptoms were fatigue (34.8%), amnesia (30.3%), concentration difficulties (24.2%), insomnia (20.5%), and depression (19.7%). Notably, no significant differences were noted in the incidence of long COVID at 24 months in terms of the number of vaccinations received. Although the neuropsychiatric quality of life improved over time, it continued to affect 32.7% of participants. Symptoms of long COVID, particularly neuropsychiatric symptoms, tend to persist over time, and COVID-19 vaccination or the number of vaccinations received may not significantly affect the incidence of long COVID.
MeSH
Quality Of Life, Vaccines, Incidence, Vaccination, Signs And Symptoms, Covid-19, Prevalence, Surveys And Questionnaires, Natural Science Disciplines, Infections, Post-Acute Covid-19 Syndrome
Cited by
- The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis. Commun Med (Lond), 2024
- Piecing together the narrative of #longcovid: an unsupervised deep learning of 1,354,889 X (formerly Twitter) posts from 2020 to 2023. Front Public Health, 2024
- The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view. Biomedicines, 2024
- Neuroinflammatory imaging markers in white matter: insights into the cerebral consequences of post-acute sequelae of COVID-19 (PASC). Res Sq, 2024
- Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: prospective cohort study. Sci Rep, 2024
- Prevalence and characteristics of long COVID-19 in Jordan: A cross sectional survey. PLoS One, 2024
- Association between Mexican vaccination schemes and the duration of long COVID syndrome symptoms. Sci Rep, 2025
- Long COVID and Its Impacts: A Case-Control Study in Brazil. Biomedicines, 2025
- Clinical and functional assessment of SARS-CoV-2 sequelae among young marines - a panel study. Lancet Reg Health Am, 2024
- Low-Dose naltrexone restored TRPM3 ion channel function in natural killer cells from long COVID patients. Front Mol Biosci, 2025
- Post-COVID syndrome prevalence: a systematic review and meta-analysis. BMC Public Health, 2024
- Long COVID Among Undocumented Latino Immigrant Populations in the Emergency Department. JAMA Netw Open, 2024
- Assessing the Quality of Life, Coping Strategies, Anxiety and Depression Levels in Patients with Long-COVID-19 Syndrome: A Six-Month Follow-Up Study. Diseases, 2024
- Higher Post-Acute Health Care Costs Following SARS-CoV-2 Infection Among Adults in Ontario, Canada. J Multidiscip Healthc, 2024
- The Association of Long COVID-19 Symptoms, Physical Function, and Activities of Daily Living Among Older Women. J Am Geriatr Soc, 2025
- Awe reduces depressive symptoms and improves well-being in a randomized-controlled clinical trial. Sci Rep, 2025
- Major Depressive Disorder in Long COVID and Exposure to Pro-Inflammatory Cytokines During Infection by SARS-CoV-2. Psychiatr Res Clin Pract, 2025
- Profiling the persistent and episodic nature of long COVID symptoms and the impact on quality of life and functional status: a cohort observation study. J Glob Health, 2025
- Memory complaints after COVID-19: a potential indicator of primary cognitive impairment or a correlate of psychiatric symptoms? Transl Psychiatry, 2024
- Long COVID Clusters of Symptoms Persist beyond Two Years after Infection: Insights from the CARDIO COVID 20-21 Registry. Viruses, 2024